Do you want to read an article? Please log in or register.
Diabetes is Associated with Increased Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
Diabetes - General
RECOMMENDED
Related content
Diabetes - GeneralType 2 Diabetes
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Diabetes Care.
Mantovani A, Byrne CD, Bonora E, Targher G
doi: 10.2337/dc17-1902.
COMMENTED
Diabetes - GeneralDiabetic Complications
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
Lancet Diabetes Endocrinol.
Zaharia OP, Strassburger K, Strom A, Bönhof GJ, Karusheva Y, Antoniou S, Bódis K, Markgraf DF, Burkart V, Müssig K, Hwang JH, Asplund O, Groop L, Ahlqvist E, Seissler J, Nawroth P, Kopf S, Schmid SM, Stumvoll M, Pfeiffer AFH, Kabisch S, Tselmin S, Häring HU, Ziegler D, Kuss O, Szendroedi J, Roden M, German Diabetes Study Group.
doi: 10.1016/S2213-8587(19)30187-1.
COMMENTED
Obesity and Bariatric Surgery
Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
doi: 10.1016/j.metabol.2020.154244.
Diabetes - GeneralType 2 Diabetes
Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial
Diabetes Care.
Basu S, Raghavan S, Wexler DJ, Berkowitz SA
doi: 10.2337/dc17-2252.
Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
Diabetologia.
Eriksson JW, Lundkvist P, Jansson PA, Johansson L, Kvarnström M, Moris L, Miliotis T, Forsberg GB, Risérus U, Lind L, Oscarsson J
doi: 10.1007/s00125-018-4675-2.
COMMENTED
Type 2 DiabetesPediatric Diabetes
Non-alcoholic fatty liver disease in pediatric type 2 diabetes: metabolic and histologic characteristics in 38 subjects
Pediatr Diabetes.
Newfield RS, Graves CL, Newbury RO, Schwimmer JB, Proudfoot JA, Say DS, Feldstein AE
doi: 10.1111/pedi.12798.
Type 2 Diabetes
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: a large multinational cohort study
Diabetes Obes Metab.
Birkeland KI, Bodegard J, Eriksson JW, Norhammar A, Haller H, Linssen GCM, Banerjee A, Thuresson M, Okami S, Garal-Pantaler E, Overbeek J, Mamza JB, Zhang R, Yajima T, Komuro I, Kadowaki T
doi: 10.1111/dom.14074.
Type 2 Diabetes
Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes
Diabetes Care
Lee CH, Seto WK, Lui DT, Fong CH, Wan HY, Cheung CY, Chow WS, Woo YC, Yuen MF, Xu A, Lam KS
doi: 10.2337/dc21-0131
Pediatric Diabetes
Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven nonalcoholic fatty liver disease
J Hepatol.
Nobili V, Mantovani A, Cianfarani S, Alisi A, Mosca A, Rita Sartorelli M, Maffeis C, Loomba R, Byrne CD,
Targher G
doi: 10.1016/j.jhep.